期刊文献+

介导HCV入胞相关分子的研究进展 被引量:2

原文传递
导出
摘要 丙型肝炎病毒(HCV)受体一直是HCV研究的热点之一,除了已经提出的可能受体:CD81、低密度脂蛋白受体、粘多糖、清道夫受体及C型(钙离子依赖型)凝集素DC/L—SIGN等,目前研究者又发现了新的受体claudin、occludin等。本文就上述HCV受体相关分子的研究进展作一综述。
作者 姚敏 吕欣
出处 《国际病毒学杂志》 2010年第2期33-37,共5页 International Journal of Virology
基金 国家自然科学基金项目30600021资助
  • 相关文献

参考文献33

  • 1Bartosch B,Cosset F L.Studying HCV cell entry with HCV pseudoparticles (HCVpp).Methods Mol Biol,2009,510:279-293.
  • 2Lindenbach B.D.,Evans M.J.,Syder A.J.,et al.Complete replication of hepatitis C virus in cell culture.Science,2005,309(5734):623-626.
  • 3Seigneuret,M.Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81:conserved and variable structural domains in the tetraspanin superfamily.Biophys J,2006,90,212-227.
  • 4Yi M,Villanueva RA,Thomas DL,et al.From the Cover; Production of infectious genotype la hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.Proc Natl Acad Sci U S A,2006,103(7):2310-2315.
  • 5Akazawa D,Date T,Morikawa K.CD81 expression is important for the permissiveness of huh7 cell clones for heterogeneous hepatitis C virus infection.J Virol,2007,81:5036-5045.
  • 6Meuleman P,Hesselgesser J,Paulson M.Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.Hepatology,2008,48(6):1761-1768.
  • 7Brazzoli M.,Bianchi A.,Filippini S..CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.J Virol,2008,82:8316-8329.
  • 8Helle F.,Dubuisson J..Hepatitis C virus entry into host cells.Cell Mol Life Sci,2008,65:100-112.
  • 9Witteveldt J,Evans M J,Bitzegeio J,et al.CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.J Gen Virol,2009,90(1):48-58.
  • 10Cormier EG,Tsamis F,Kajumo F,et al.CD81 is an entry core-ceptor for hepatitis C virus.Proc Natl Acad Sci USA,2004,101 (19):7270-7274.

同被引文献18

  • 1石川,曹以诚,杜正平,卓敏.RNAi抑制丙肝病毒复制的研究进展[J].现代食品科技,2007,23(6):59-62. 被引量:3
  • 2Qiu-wei Pan,Scot D Henry,Bob J Scholte,Hugo W Tilanus,Harry LA Janssen,Luc JW van der Laan.New therapeutic opportunities for Hepatitis C based on small RNA[J].World Journal of Gastroenterology,2007,13(33):4431-4436. 被引量:4
  • 3Bendelac A,Savage P,Teyton L.The biology of NKT cells.Annu Rev Immunol,2007,25:297-336.
  • 4Borg NA,Wun KS,Kjer-Nielsen L,et al.CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature,2007,448:44-49.
  • 5Shi MQ,Wang CR,Wei GJ,et al.Experimental African trypanosomiasis:lack of effective CD1d-restricted antigen presentation.Parasite Immunol,2006,28(12):643-647.
  • 6Haraguchi K,Takahashi T,Nakahara F,et al.CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.Leuk Lymphoma,2006,47:2218-2243.
  • 7Kakimi K,Guidotti LG,Koezuka Y,et al.Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med,2000,192 (7):921-930.
  • 8Jody LB,Leon G,Stephen N,et al.Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.Immunity,2002,16:583-594.
  • 9Guidotti LG,Rochford R,Chung J,et al.Viral clearance without destruction of infected cells during acute HBV infection.Science,1999,284 (5415):825-829.
  • 10Ye L,Wang X,Wang S,et al.CD56 + T cells inhibit hepatitis C virus replication in human hepatocytes.Hepatology,2009,49:753-762.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部